Literature DB >> 15151933

Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice.

Vimal Selvaraj1, Melissa A Zakroczymski, Afia Naaz, Motoko Mukai, Young H Ju, Daniel R Doerge, John A Katzenellenbogen, William G Helferich, Paul S Cooke.   

Abstract

Equol, a metabolite of the phytoestrogen daidzein, is present at significant levels in some humans who consume soy and in rodents fed soy-based diets. Equol is estrogenic in vitro, but there have been limited studies of its activity in vivo. We evaluated equol effects on reproductive and non-reproductive endpoints in mice. Ovariectomized age-matched (30-day-old) female C57BL/6 mice were fed phytoestrogen-free diets and given a racemic mixture of equol by daily injections (0, 4, 8, 12, or 20 mg [kg body weight](-1) day(-1)) or in the diet (0, 500, or 1,000 ppm) for 12 days. Mice were killed, and serum concentrations of total and aglycone equol were measured. Total serum equol concentrations ranged from 1.4 to 7.5 microM with increasing doses of injected equol, but uterine weight increased significantly only at 12 and 20 mg (kg body weight)(-1) day(-1). Dietary equol at 500 or 1,000 ppm produced total serum equol concentrations of 5.9 and 8.1 microM, respectively, comparable with those in rodents consuming certain high-soy chows; the proportion of equol present as the free aglycone was much lower with dietary administration than injections, which may be a factor in the greater biological effects induced by injections. Dietary equol did not significantly increase uterine weight. Increasing dietary and injected equol doses caused a dose-dependent increase in vaginal epithelial thickness. Uterine epithelial proliferation was increased by equol injections at 8-20 mg (kg body weight)(-1) day(-1) and 1,000 ppm dietary equol. Neither dietary nor injected equol decreased thymic or adipose weights. In conclusion, equol is a weak estrogen with modest effects on endpoints regulated by estrogen receptor alpha when present at serum levels seen in rodents fed soy-based diets, but quantities present in humans may not be sufficient to induce estrogenic effects, although additive effects of equol with other phytoestrogens may occur.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151933     DOI: 10.1095/biolreprod.104.029512

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  20 in total

1.  Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss.

Authors:  Connie M Weaver; Leecole L Legette
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

2.  Estrogen effects on epithelial proliferation and benign proliferative lesions in the postmenopausal primate mammary gland.

Authors:  Charles E Wood; Joy M Hester; Susan E Appt; Kim R Geisinger; J Mark Cline
Journal:  Lab Invest       Date:  2008-07-07       Impact factor: 5.662

3.  Endogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice.

Authors:  Fitriya N Dewi; Charles E Wood; Johanna W Lampe; Meredith A J Hullar; Adrian A Franke; Deborah L Golden; Michael R Adams; J Mark Cline
Journal:  J Nutr       Date:  2012-08-29       Impact factor: 4.798

4.  Impact of perinatal exposure to equol enantiomers on reproductive development in rodents.

Authors:  Nadine M Brown; Stephanie L Lindley; David P Witte; Kenneth D R Setchell
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

Review 5.  Regulation of estrogen receptor beta activity and implications in health and disease.

Authors:  Elin Swedenborg; Krista A Power; Wen Cai; Ingemar Pongratz; Joëlle Rüegg
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

6.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

Review 7.  Uterine glands: development, function and experimental model systems.

Authors:  Paul S Cooke; Thomas E Spencer; Frank F Bartol; Kanako Hayashi
Journal:  Mol Hum Reprod       Date:  2013-04-25       Impact factor: 4.025

8.  Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats.

Authors:  Leecole L Legette; Berdine R Martin; Mohammad Shahnazari; Wang-Hee Lee; William G Helferich; Junqi Qian; David J Waters; Alireza Arabshahi; Stephen Barnes; Jo Welch; David G Bostwick; Connie M Weaver
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

9.  The effects of dietary treatment with S-equol on learning and memory processes in middle-aged ovariectomized rats.

Authors:  Steven L Neese; Samantha L Pisani; Daniel R Doerge; William G Helferich; Estatira Sepehr; Amar G Chittiboyina; Sateesh Chandra Kumar Rotte; Troy J Smillie; Ikhlas A Khan; Donna L Korol; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2013-12-22       Impact factor: 3.763

10.  (±)-Equol does not interact with genistein on estrogen-dependent breast tumor growth.

Authors:  Huaxin Song; Jennifer R Hughes; Russell T Turner; Urszula T Iwaniec; Daniel R Doerge; William G Helferich
Journal:  Food Chem Toxicol       Date:  2019-11-28       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.